Thuy Vu - Concepedia

Author

Thuy Vu

Amgen (United States)

Also Known As

THUY C. VU, Thuy C. Vu, Thuy Vu

Publications

851

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)University of Auckland GlaxoSmithKline (China)KU Leuven Oregon Health & Science University

About

Thuy Vu is an author at Amgen (United States) specializing in autoimmunity, medicine, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	141
2	Immunology	3	3	141
3	Autoimmune Disease	3	3	141
4	Allergy	2	2	88
5	Pharmacology	1	1	49

Thuy Vu

Publications

846

Citations

H-Index

Page 1

	Year	Citations
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment Thuy Vu, John G. Nutt, Nicholas H. G. Holford British Journal of Clinical Pharmacology	2012	180
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Clinical Pharmacology & Therapeutics	2017	95
Early onset of efficacy with erenumab in patients with episodic and chronic migraine Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper, The Journal of Headache and Pain	2018	94
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects Thuy Vu, Peiming Ma, Jiyun Sunny Chen, Pharmaceutical Research	2017	93
Population Pharmacokinetics of Golimumab, an Anti‐Tumor Necrosis Factor‐α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis Zhenhua Xu, Thuy Vu, Howard Lee, The Journal of Clinical Pharmacology	2009	90
Dexmedetomidine hemodynamics in children after cardiac surgery Amanda L. Potts, Brian J. Anderson, Nicholas H. G. Holford, Pediatric Anesthesia	2010	74
Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics Lei Zhou, Sarah Hoofring, Yu Wu, The AAPS Journal Immunocytochemical TechniqueAutoimmune DiseaseHumoral ResponseImmunologyAntibody Level Reveals	2012	53
Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor Tarundeep Kakkar, Cynthia Sung, Leonid Gibiansky, Pharmaceutical Research Population PkAllergyAutoimmune DiseaseMedicineImmunodeficiencies	2011	49
Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease Thuy Vu, John G. Nutt, Nicholas H. G. Holford British Journal of Clinical Pharmacology	2012	44
Pharmacokinetic and Pharmacodynamic Relationship of AMG 811, An Anti-IFN-γ IgG1 Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus Ping Chen, Thuy Vu, Adimoolam Narayanan, Pharmaceutical Research AllergyAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupusImmunodeficiencies	2014	39

Page 1